Real-Life Effectiveness and Safety of Glecaprevir/Pibrentasvir for Korean Patients with Chronic Hepatitis C at a Single Institution

BACKGROUND/AIMS: Glecaprevir/pibrentasvir (G/P) is a combination of direct-acting antiviral agents that is an approved treatment for chronic infections by all six hepatitis C virus (HCV) genotypes. However, there are limited data on the effect of G/P in Korean patients in actual real-world settings....

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Young Joo, Woo, Hyun Young, Heo, Jeong, Park, Sang Gyu, Hong, Young Mi, Yoon, Ki Tae, Kim, Dong Uk, Kim, Gwang Ha, Kim, Hyung Hoi, Song, Geun Am, Cho, Mong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129668/
https://www.ncbi.nlm.nih.gov/pubmed/32839365
http://dx.doi.org/10.5009/gnl19393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129668/
https://www.ncbi.nlm.nih.gov/pubmed/32839365
http://dx.doi.org/10.5009/gnl19393

Ejemplares similares